We have hit the dsmc review point for covid in Bra

We have hit the dsmc review point for covid in Brazil, brazil trial was not shut down only paused for data prep. This FDA BS only has to do with US and most likely Amarex at the helm. If there is anything more than a short term damage to cytodyn because of amarex cydy ans Sidley will own amarex and part of nsf. Meanwhile this does not affect cydy 2 biggest gems NASH BTD and MTnBC BTD as well as basket trial cancers. This bolagna was put out like a crappy appetizer on a menu that the main course is surf and turf. I think there will be filet meat and lobster tom morning on the call.